Beta · prototype— This site is under construction: rankings, texts and features change every week.

PharmEasy

Active#2 worldwide · Online pharmacy

Online pharmacy

HQIndia
Last roundRights issue · Apr 2024

Uback rankings

How the AI ranks →
RankingTierRankEditionNext update
Online pharmacy · worldwideTop 6#2Edition 0 (beta) · Sep 20266 Feb 2027
Rank historySep 2026 · #2 Online pharmacyFirst edition: no movements yet.

Estimated valuation

AI · Online pharmacy ranking (worldwide)
≈ USD 600MUSD 400–900M · Hundreds of M$ Medium confidence
Anchor
Last known equity round: Rights issue · USD 216M · Apr 2024
Published valuation
USD 456M implied by an investor's fund mark · Dec 2024

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Funding history

DateRoundAmountTypeInvestorsSource
Apr 2024Rights issueUSD 216MEquity—techcrunch.com

Rounds as cited by Uback’s rankings and their sources. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of PharmEasy as a PDF, on one of three angles only:

ValuationWhat is PharmEasy worth?
Versus competitorsHow does it compare?
Who should acquire itStrategic buyers, and why
Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication and never change the rank.

Comparable companies in online pharmacy

Full online pharmacy ranking →

Sources. techcrunch.com · entrackr.com · business-standard.com

Last updated: Sep 2026Report an error

Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.